Compound ID | 1051

CP-32,656

Class: Ansamycin

Spectrum of activity: Gram-positive  &  Gram-negative
Details of activity: Broad spectrum of resistance against gram +ve and -ve bacteria
Institute where first reported: Pfizer Inc
Year first mentioned: 1976
Highest developmental phase: Preclinical
Development status: Inactive

AntibioticDB is supported by GARDP.

If you have feedback, experience problems, or are interested in a collaboration, please contact us. | Terms and conditions

The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.